Enhancer Rewiring Orchestrates Inflammation and Loss of Cell Identity During Muscle Stem Cell Aging
Aging Cell · 2026
DOI: 10.1111/acel.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Changyou Shi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Inflammation, Cellular Senescence, Muscle, Skeletal, Stem Cells. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Loss of regeneration is a key feature of aging organs, often linked to stem cell exhaustion. Skeletal muscle stem cells (MuSCs) undergo age‐related numerical and functional decline, contributing to reduced regenerative potential. Using low‐input multi‐omics, we systematically profiled the epigenome, transcriptome, and 3D genome of MuSCs from individual mice across 3 age groups (young, old, and geriatric) and both sexes. At baseline, young male MuSCs showed reduced expression of cell cycle‐related mRNAs. In aged mice, particularly males, MuSCs exhibited early alterations (emerging during the transition from young to old age) including enhanced proinflammatory signaling, and loss of cell identity. Late alterations (emerging during the transition from old to geriatric age) included heightened inflammation, widespread enhancer activation, and extensive 3D genome rewiring. Proinflammatory pathways were enriched for interferon signaling and correlated with endogenous retroviral expression and NFκB activity. Late‐stage epigenome and 3D genome rewiring reflected downstream degenerative changes in muscle organization, response to cytokines, and loss of myogenic identity. Thus, progressive molecular shifts may explain the aggravated proliferative deficit and functional impairment observed in MuSCs during aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, Maryland, USA.
- Department of Neurology and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
- Flow Cytometry Unit, National Institute on Aging, NIH, Baltimore, Maryland, USA.
- Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, Missouri, USA.
- Computational Biology and Genomics Core, Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, Maryland, USA.
- Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA.
ORCID-Profile: Chang-Yi Cui, Payel Sen
Förderung
- NIA NIH HHS
- NIH HHS
- National Science Foundation
- American Federation for Aging Research
- Intramural NIH HHS
- National Institutes of Health
Zitieren
APA
Shi, C., Yang, N., Pizano, E., Wang, L., Occean, J. R., Cui, C. Y., Liu, L., Dunn, C., Boadu, F., Meng, Q., Banskota, N., Yang, J. H., Fan, J., De, S., Cheng, J., Rando, T. A., Sartorelli, V., & Sen, P. (2026). Enhancer Rewiring Orchestrates Inflammation and Loss of Cell Identity During Muscle Stem Cell Aging. Aging Cell. https://doi.org/10.1111/acel.70289
Vancouver
Shi C, Yang N, Pizano E, Wang L, Occean JR, Cui CY, et al. Enhancer Rewiring Orchestrates Inflammation and Loss of Cell Identity During Muscle Stem Cell Aging. Aging Cell. 2026. doi:10.1111/acel.70289
BibTeX
@article{Shi2026,
author = {Shi, Changyou and Yang, Na and Pizano, Evelyn and Wang, Lin and Occean, James R and Cui, Chang-Yi and Liu, Ling and Dunn, Christopher and Boadu, Frimpong and Meng, Qiong and Banskota, Nirad and Yang, Jen-Hao and Fan, Jinshui and De, Supriyo and Cheng, Jianlin and Rando, Thomas A and Sartorelli, Vittorio and Sen, Payel},
title = {Enhancer Rewiring Orchestrates Inflammation and Loss of Cell Identity During Muscle Stem Cell Aging},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70289}
}
EUVIMED